The Effect of Astaxanthin Supplementation on Serum Oxidized LDL Levels in Adults with Obesity — an Open-Label Randomized Trial
Clinical Diabetology · 30.10.2026 · 15 (5) · 217-218
DOI: 10.5603/cd.112471 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Diabetology, online erschienen am 30.10.2026. Verfasst von Winda Mulyamin und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mulyamin, W., Kurniawan, L. B., Aminuddin, A., Leman, Y., Zainuddin, A. A., Pangkahila, W., Djabir, Y. Y., & As’ad, S. (2026). The Effect of Astaxanthin Supplementation on Serum Oxidized LDL Levels in Adults with Obesity — an Open-Label Randomized Trial. Clinical Diabetology, 15(5), 217-218. https://doi.org/10.5603/cd.112471
Vancouver
Mulyamin W, Kurniawan LB, Aminuddin A, Leman Y, Zainuddin AA, Pangkahila W, et al. The Effect of Astaxanthin Supplementation on Serum Oxidized LDL Levels in Adults with Obesity — an Open-Label Randomized Trial. Clinical Diabetology. 2026;15(5):217-218. doi:10.5603/cd.112471
BibTeX
@article{Mulyamin2026,
author = {Mulyamin, Winda and Kurniawan, Liong Boy and Aminuddin, Aminuddin and Leman, Yanti and Zainuddin, Andi Alfian and Pangkahila, Wimpie and Djabir, Yulia Yusrini and As’ad, Suryani},
title = {The Effect of Astaxanthin Supplementation on Serum Oxidized LDL Levels in Adults with Obesity — an Open-Label Randomized Trial},
journal = {Clinical Diabetology},
year = {2026},
volume = {15},
number = {5},
pages = {217--218},
doi = {10.5603/cd.112471}
}
EUVIMED